Oral lichen planus (OLP) is a chronic inflammatory condition of the mouth’s lining, driven by the immune system attacking its own tissue. It affects roughly one to two percent of the general population, shows up most often in middle-aged women, and tends to persist for years with unpredictable flares and quiet stretches. The condition ranges from barely noticeable white patches to painful erosions that make eating miserable, and while it is classified as a potentially malignant disorder, the actual risk of it turning cancerous is low. Understanding what OLP is, what sets it off, and how to manage it can spare a lot of unnecessary anxiety and steer you toward treatments that genuinely help.
What It Looks and Feels Like
OLP can show up in several different forms, sometimes more than one at the same time. The classic presentation is a lacy network of fine white lines, called Wickham’s striae, on the inner cheeks. You might never notice these if nobody points them out, and they often cause no pain at all. But OLP also appears as red, thinned-out patches (atrophic form), raw erosions or ulcers (erosive form), raised plaques, or, rarely, fluid-filled blisters. It favors the inner cheeks, tongue, and gums, though it can appear on any oral surface.
Pain depends almost entirely on which form you have. The white reticular type is usually painless. The erosive and atrophic types are the ones that hurt, sometimes intensely, especially when you eat spicy, acidic, or crunchy food. In one case series, the erosive form was the most common presentation, found in over half of patients studied.1PubMed. Factors associated with clinical characteristics and symptoms in a case series of oral lichen planus The disease evolves through intermittent flares and can shift between forms over time, so a patient who starts with painless white lines may eventually develop erosions, or vice versa.2PubMed. Oral Lichen Planus: An Update on Diagnosis and Management
Beyond pain, people with OLP frequently report changes in taste, a burning sensation even in the absence of visible ulcers, and difficulty eating their usual diet. Many end up avoiding foods they enjoy because spice, heat, or citrus triggers discomfort. That functional limitation, particularly dissatisfaction with the foods they can eat and changes in how their mouth tastes, can significantly affect quality of life.3PubMed Central. The relationship between clinical symptoms of oral lichen planus and quality of life related to oral health
What Is Happening Under the Surface
OLP is a T-cell mediated autoimmune disease. In plain terms, a certain type of immune cell — cytotoxic T cells — mistakenly identifies the cells lining the base of the mouth’s surface tissue as a threat and kills them.4PubMed Central. Oral lichen planus: An update on pathogenesis and treatment This targeted destruction of basal keratinocytes (the cells that anchor and replenish the mouth’s lining) is what produces the thinning, erosion, and ulceration seen in more severe forms.
The process involves both an antigen-specific arm, where the immune cells are trained against something on the surface of those lining cells, and a broader inflammatory cascade.5PubMed. The pathogenesis of oral lichen planus Research has found abnormal patterns of a whole suite of inflammatory signaling molecules in OLP tissue, saliva, and blood, reflecting deep immune dysregulation rather than a single misfiring switch. Gene variations in some of those signaling molecules also appear to affect who is susceptible to the condition in the first place.6PubMed Central. Inflammation-related cytokines in oral lichen planus: an overview
What triggers the immune system to start this attack remains unclear. That is what makes OLP frustrating for both patients and clinicians: there is no single cause you can point to and remove. Instead, a web of genetic predisposition, environmental exposures, and immune triggers seems to converge differently in different people.
Known Triggers and Lookalike Conditions
Although the root cause of OLP is not fully understood, several factors can either trigger the disease or produce something that looks very much like it.
Dental Materials
Amalgam (“silver”) fillings contain mercury compounds, and in some patients these provoke a localized immune reaction in the mouth tissue that sits right against the filling. A study from the Archives of Dermatology found that contact allergy to mercury compounds plays an important role in OLP, particularly when white or red patches sit in direct contact with an amalgam restoration and the patient has no lichen planus on the skin. In those cases, replacing the fillings led to significant improvement in nearly all patients who tested positive for mercury allergy on patch testing.7PubMed. Oral lichen planus and allergy to dental amalgam restorations However, not everyone with amalgam-adjacent lesions tests positive for allergy. Research from the Basque Country found allergic reactivity in less than a third of patients with amalgam-associated lesions, suggesting that mechanisms beyond simple allergy, possibly including corrosion products from the metal, also contribute.8PubMed Central. Oral lichenoid lesions associated with amalgam restorations: A prospective pilot study addressing the adult population of the Basque Country
The distinction matters clinically. Lesions caused by dental materials are often called oral lichenoid lesions rather than true OLP, because they tend to resolve or improve once the offending material is removed. True OLP persists regardless of what is in your mouth.
Medications
A number of drugs can produce mouth lesions that mimic OLP. The most commonly implicated categories are nonsteroidal anti-inflammatory drugs (like ibuprofen), blood-pressure medications (particularly ACE inhibitors), antimalarials, certain diabetes drugs, and beta blockers.9PubMed Central. Oral Lichenoid Lesions – A Review and Update – Section: Drugs and medications A systematic review of drug-induced cases found the medications most frequently reported were methyldopa, interferon-alpha, and newer agents like imatinib and infliximab.10PubMed. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review If you develop mouth lesions shortly after starting a new medication, it is worth flagging for your doctor.
Stress and Anxiety
Patients with OLP frequently report that flares coincide with stressful periods. This is not just perception. Studies have found a positive correlation between anxiety levels and salivary cortisol (the body’s primary stress hormone) in OLP patients, suggesting that psychological stress genuinely contributes to the disease’s activity.11PubMed Central. Association of salivary cortisol and anxiety levels in lichen planus patients Stress does not cause OLP on its own, but it appears to worsen it. Some clinicians now recommend psychological support alongside conventional treatment.
Getting a Diagnosis
Diagnosing OLP is trickier than it sounds. The classic white lacy pattern on the cheeks is distinctive enough that an experienced clinician can often recognize it on sight. But erosive and atrophic forms look a lot like other conditions, including a blister-forming autoimmune disease called mucous membrane pemphigoid, drug reactions, and even early oral cancer. A biopsy is typically needed to confirm the diagnosis, and even then, the microscopic features of OLP overlap with those of lichenoid reactions from drugs or materials.12PubMed Central. Diagnostic Criteria of Oral Lichen Planus: A Narrative Review
Because the erosive form of OLP and mucous membrane pemphigoid can look similar both clinically and under the microscope, distinguishing them sometimes requires additional testing. Researchers have found that analyzing T-cell subsets using flow cytometry could help differentiate the two conditions, though this technique is not yet routine in clinical practice.13PubMed Central. Flow cytometry helps differentiate between mucous membrane pemphigoid and erosive oral lichen planus On the experimental side, autofluorescence spectroscopy, which shines specific wavelengths of light on oral tissue and measures the reflected signal, has shown promising results for non-invasive diagnosis, with one study achieving sensitivity and specificity around 80 to 90 percent at certain wavelengths.14PubMed. Optical diagnosis of oral lichen planus: A clinical study on the use of autofluorescence spectroscopy combined with multivariate analysis For now, though, a biopsy combined with clinical evaluation remains the diagnostic standard.
Treatment Options
There is no cure for OLP. Treatment aims to control symptoms during flares, heal erosions, and extend the quiet periods in between. The first-line approach for symptomatic OLP is topical corticosteroids applied directly to the affected area, usually as gels or pastes that stick to the wet mouth surface.
Topical Steroids
A Cochrane systematic review found that topical corticosteroids may reduce pain in symptomatic OLP compared to placebo, though the overall confidence in that finding was rated low because of small study sizes.15PubMed Central. Interventions for treating oral lichen planus: corticosteroid therapies Despite that cautious assessment from the review, topical steroids remain the standard treatment worldwide because clinicians consistently see them work in practice. Among the available options, fluocinonide, dexamethasone, clobetasol, and triamcinolone are the most commonly used, with fluocinonide considered the most cost-effective when balancing efficacy, side effects, and expense.16PubMed Central. Oral lichen planus: comparative efficacy and treatment costs-a systematic review
The main risk with topical steroids used in the mouth is oral candidiasis (thrush), a fungal overgrowth encouraged by local immune suppression. Your dentist or doctor may prescribe an antifungal rinse to use alongside the steroid to prevent this.
Calcineurin Inhibitors
When steroids are not enough, topical tacrolimus or pimecrolimus are the usual second-line choices. These drugs suppress the immune response through a different mechanism and can be effective for erosive OLP that does not respond to steroids. In one study, tacrolimus 0.1% applied twice daily for eight weeks produced total or near-total remission of pain and lesions in about 80 percent of patients whose OLP had resisted steroid treatment.17PubMed Central. Oral lichen planus treated with tacrolimus 0.1% Another study that specifically enrolled steroid-resistant patients found that switching to tacrolimus produced a roughly 73 percent reduction in a combined measure of redness, erosion, and ulceration, whereas the prior steroid treatment had produced essentially no improvement.18Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. Efficacy and safety of tacrolimus for local steroid-ineffective oral lichen planus
Calcineurin inhibitors can cause a burning or stinging sensation when first applied, which usually fades with continued use. There was once concern about a theoretical cancer risk with long-term use, based on warning labels for skin applications, but this has not been borne out in oral use at the doses typically prescribed.
Low-Level Laser Therapy
An approach gaining traction is low-level laser therapy (LLLT), sometimes called photobiomodulation. This uses specific wavelengths of low-power light directed at lesions. A recent meta-analysis found that LLLT significantly improved lesion severity and reduced recurrence rates, though its pain-relieving effects were strongest over the long term (beyond 12 weeks) rather than immediately after treatment.19PubMed. Effects of Low-Level Light Therapy on Pain and Related Lesions in Patients with Oral Lichen Planus: A Systematic Review and Meta-Analysis Individual studies have reported dramatic results, including complete disappearance of erosive lesions over about two months of treatment with no side effects.20PubMed Central. Clinical Assessment of the Efficiency of Low Level Laser Therapy in the Treatment of Oral Lichen Planus LLLT is appealing because it avoids the systemic and local side effects of drugs, but it requires multiple in-office sessions and is not yet widely available.
Emerging Therapies
For severe, treatment-resistant OLP, a new class of drugs called JAK inhibitors is generating interest. These are oral medications that block specific signaling pathways used by immune cells. Case reports have described patients with intractable erosive OLP, unresponsive to all standard treatments, who responded dramatically to ritlecitinib, a JAK3 inhibitor, with improvement beginning within 48 hours.21JAAD Case Reports. Erosive oral lichen planus successfully treated with JAK3/TEC inhibitor ritlecitinib: A case report Another JAK inhibitor, upadacitinib, has been reported to produce about 70 percent improvement within one month in a patient who had failed multiple prior treatments.22Journal of Drugs in Dermatology. Oral Lichen Planus Successfully Treated With Upadacitinib These are isolated case reports rather than clinical trials, so it is far too early to call them proven treatments. But the biology makes sense: JAK3 appears to be upregulated in OLP lesions, so blocking it targets the immune cascade that drives the disease. This is an area to watch closely.
The Cancer Question
OLP is classified by the World Health Organization as a potentially malignant disorder, which sounds alarming but needs context. A 25-year population-based study found that about 3 percent of OLP patients developed oral squamous cell carcinoma over two decades of follow-up. Those with OLP were roughly five times more likely to develop this cancer than matched individuals without OLP, and the median time to cancer development was about 15 years earlier than in the comparison group.23PubMed Central. Incidence of Squamous Cell Carcinoma in Oral Lichen Planus: A 25-Year Population-Based Study
That five-fold relative risk sounds high, but the absolute risk, roughly 3 percent over 20 years, is low in everyday terms. The practical takeaway is that OLP does warrant regular monitoring, typically a dental or oral medicine check every six to twelve months, but it is not a condition that should keep you up at night worrying about cancer. Any new, persistent change in an OLP lesion, particularly a thickening lump or an ulcer that does not heal, should be biopsied promptly. Researchers have tried to find reliable tissue markers (like the p53 protein) that could predict which OLP lesions are more likely to turn malignant, but results have been inconsistent and no single biomarker is currently useful for that purpose.24PubMed Central. Significance of immunohistochemistry biomarkers in prediction of malignant transformation of oral lichen planus: A systematic review
Connections to Other Conditions
OLP does not exist in isolation. Lichen planus can also affect the skin (as itchy, flat-topped purple bumps), the nails, the scalp, and genital mucosa. Oral involvement is often the most persistent site, and some patients have OLP with no other affected areas, while others develop lesions in several places simultaneously.25PubMed. Oral lichen planus Women with oral lichen planus should be aware that genital lichen planus can occur concurrently and is sometimes overlooked because patients do not connect the two, or are reluctant to mention genital symptoms.
A well-documented association exists between OLP and hepatitis C virus (HCV) infection, although the strength of this link varies dramatically by geography. The prevalence of HCV among lichen planus patients ranges from as low as 4 percent in France to as high as 62 percent in Japan.26PubMed Central. Association of lichen planus with hepatitis C virus infection This geographic variation appears to mirror the background rates of hepatitis C in those populations, making it difficult to determine how much of the association is causal versus coincidental.27PubMed Central. Association of oral lichen planus with chronic C hepatitis. Review of the data in literature Still, many clinicians will screen newly diagnosed OLP patients for hepatitis C, particularly in regions where HCV is more prevalent.
The Oral Microbiome in OLP
An increasingly studied dimension of OLP is the composition of bacteria in saliva. Researchers comparing the saliva of OLP patients with healthy controls have found distinct differences in the bacterial communities. In erosive OLP specifically, certain genera of bacteria are overrepresented while others are depleted compared to both non-erosive OLP and healthy mouths.28PubMed Central. Dysbiosis of saliva microbiome in patients with oral lichen planus Whether these shifts cause the disease, result from the inflammation, or simply co-occur is not yet clear. But the microbial angle opens up the possibility that probiotics or other microbiome-targeted therapies could eventually play a role in managing OLP. That remains speculative for now.
Vitamin D as an Add-On
A systematic review looking at vitamin D supplementation in OLP patients found that across all included studies, adding vitamin D to standard steroid treatment produced noticeable improvement in symptoms. The effect was seen when vitamin D was used as an adjunct, not a replacement for steroids.29PubMed Central. Vitamin D in the Treatment of Oral Lichen Planus: A Systematic Review The studies were small, and the review’s authors called for larger trials to confirm the benefit. Given that vitamin D supplementation is inexpensive and generally safe, it is a reasonable conversation to have with your doctor, especially if your blood levels are low. It is not something to rely on as a sole treatment.